Treatment option | Protocol |
Dietary therapy |
|
| |
| |
| |
Topical corticosteroids |
|
– children: 440–880 μg/day ×6–8 weeks | |
– adolescents/adult: 880–1760 μg/day ×6–8 weeks | |
| |
| |
Systemic (oral) corticosteroids |
|
– divide into twice daily dosing ×4 weeks then taper over 6 weeks | |
| |
– children: 1–2 mg daily ×3–4 months | |
– adults*: 2–12 mg daily ×2–6 weeks | |
Montelukast |
|
| |
| |
Mepolizumab |
|
*Presented in abstract form only.62 67
This table is modified from Yan and Shaffer,21 with permission from the publishers.